Elizabeth M Jaffee

78PUBLICATIONS
469CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Sequence analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Sep 04, 2026
Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer.

|Aug 14, 2026
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.

|Jul 23, 2026
Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.

|Jul 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

|Jun 26, 2026
Peripheral Th17 Immune Signature Associates with Excellent Response to Anti-PD-1/Anti-PD-L1 Therapy across Solid Tumors.

|Jun 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.

Pageof 13

Frequent Collaborators

21 joint publications

Mark Yarchoan

20 joint publications

Won Jin Ho

16 joint publications

Elana J Fertig

15 joint publications

Ludmila Danilova